Physical Activity in Pulmonary Arterial Hypertension during Pandemic COVID-19 and the Potential Impact of Mental Factors

Article Psychology, Clinical

The Fear of COVID-19 Scale: Development and Initial Validation

Daniel Kwasi Ahorsu et al.

Summary: The Fear of COVID-19 Scale is a reliable and valid tool for assessing fear of COVID-19 among the general population and can help alleviate individual fears of COVID-19.

INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts

Amanda E Paluch et al.

Lancet Public Health (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial

Ekkehard Gruenig et al.

Summary: This study demonstrated that exercise training for patients with PAH and CTEPH can significantly improve quality of life, WHO functional class, and peak oxygen consumption, and is feasible, safe, and well-tolerated as an add-on to medical therapy.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Critical Care Medicine

A Mobile Health Intervention to Increase Physical Activity in Pulmonary Arterial Hypertension

Anna R. Hemnes et al.

Summary: This study demonstrated the feasibility of an automated text message-based intervention to increase physical activity in PAH patients, with positive effects on quality of life and body composition. Additional studies are needed to further explore the impact of this intervention on clinical outcomes.

CHEST (2021)

Add to Collection

Article Immunology

COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination

Maria Wieteska-Milek et al.

Summary: The incidence of COVID-19 infection in patients with PAH and CTEPH is similar to that in the general population, but the mortality rate is higher. COVID-19 vaccination is recommended for these patients. Some patients refused vaccination due to concerns about adverse events and age had an impact on willingness to be vaccinated. Adverse events were more common in younger patients, but the vaccines were overall considered safe for PAH/CTEPH patients.

VACCINES (2021)

Add to Collection

Article Multidisciplinary Sciences

Experiencing fear during the pandemic: validation of the fear of COVID-19 scale in Polish

Irena Pilch et al.

Summary: This study validated the Polish version of the Fear of COVID-19 Scale (FCV-19S), showing that it had a unidimensional structure, good reliability, and correlated as predicted with other variables.

PEERJ (2021)

Add to Collection

Letter Critical Care Medicine

Daily Step Counts Are Associated with Hospitalization Risk in Pulmonary Arterial Hypertension

Jennifer Marvin-Peek et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Psychiatry

Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension

Da Hee Park et al.

Summary: The study found that the Covid-19 pandemic had little impact on anxiety, depression, and quality of life in patients with PAH. Established PAH therapy and access to medical care were not significantly affected. Further studies on the prolonged duration of the ongoing Covid-19 pandemic are needed.

FRONTIERS IN PSYCHIATRY (2021)

Add to Collection

Article Medicine, General & Internal

Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the Pandemic

Maria Wieteska-Milek et al.

Summary: The study found that during the COVID-19 pandemic, patients with PAH and CTEPH experienced high levels of fear, anxiety, and depression, with higher levels of fear observed in women and the elderly. Higher fear levels increased the likelihood of anxiety, but not depression. A history of COVID-19 increased the risk of developing both anxiety and depression in these patients.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association of daily physical activity with psychosocial aspects and functional capacity in patients with pulmonary arterial hypertension: a cross-sectional study

Layse Nakazato et al.

Summary: The study investigated the association between physical activity level in patients with pulmonary arterial hypertension and psychological disorders, health-related quality of life, daily activities, clinical factors, and functional capacity. Findings suggest that beyond physical and hemodynamic factors, other aspects may impact the daily physical activity of patients with pulmonary arterial hypertension.

PULMONARY CIRCULATION (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial

Ekkehard Gruenig et al.

Summary: This study is the first multicentre and largest randomized, controlled study on the feasibility, safety, and efficacy of exercise training as add-on to medical therapy in PAH and CTEPH patients, showing that exercise training can improve patients' exercise capacity, quality of life, and WHO functional class.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Medicine, General & Internal